Quick Heal Technologies (QUICKHEAL) Q4 24/25 earnings summary

Executive summary

• FY25 was marked by revenue decline and negative EBITDA, driven by consumer headwinds and delayed government deals, but saw a strategic shift toward enterprise and cloud segments, with new product launches and international expansion.

• The company maintained market leadership in Indian consumer antivirus with over 30% share, while expanding enterprise offerings and onboarding new partners in Europe and North America.

• Multiple new products were launched, including SIA (Seqrite Intelligence Assistant), AntiFraud.ai, and Seqrite Threat Intelligence Solution, with strong renewal momentum and marquee customer acquisitions.

• The group comprises Quick Heal Technologies America Inc. and Seqrite Technologies DMCC as wholly owned subsidiaries.

Financial highlights

• FY25 consolidated revenue was INR 279.53 crore, down from INR 291.75 crore in FY24; EBITDA was negative INR 6.6 crore, and PAT fell to INR 5.04 crore.

• Consumer revenue dropped 9.2% YoY to INR 185.7 crore; enterprise revenue grew 1.5% YoY to INR 121.2 crore.

• Gross margin remained strong at 97.1% for FY25.

• Cash and cash equivalents at year-end were INR 20.8 crore (consolidated), with total assets of INR 525 crore.

• Dividend payout for FY25 was INR 16.13 crore, up from INR 13.29 crore in FY24.

Outlook and guidance

• Management is confident about FY26, citing a strong and diversified pipeline, improved product mix, and focus on expanding into higher customer segments and international markets.

• Targeting growth in cloud business, which saw a 47% CAGR over two years, and continued investment in AI-driven cybersecurity.